Historique de carrière de Israel Rios
Anciens postes connus de Israel Rios
Sociétés | Poste | Début | Fin |
---|---|---|---|
SCICLONE PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2005 | 06/04/2012 |
DENDREON CORPORATION | Directeur Technique/Scientifique/R&D | 01/01/2003 | 01/01/2005 |
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Berlex, Inc. manufactured pharmaceutical company. It developed novel diagnostics and therapeutics, which address unmet medical needs. It used to researches, develops, manufactures and markets ethical pharmaceuticals in five strategic areas such as female healthcare, diagnostic imaging, dermatology, oncology and therapeutics. The company was headquartered in Wayne, NJ | Corporate Officer/Principal | 01/01/2002 | 01/01/2002 |
Marion Merrell Dow, Inc. | Corporate Officer/Principal | 01/01/1984 | 01/01/1993 |
BRISTOL-MYERS SQUIBB COMPANY | Directeur Technique/Scientifique/R&D | 01/01/1978 | 01/01/1984 |
Formation de Israel Rios
Central University of Venezuela | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Vénézuela | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Entreprise privées | 4 |
---|---|
SciClone Pharmaceuticals LLC
SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Marion Merrell Dow, Inc. | Health Technology |
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Berlex, Inc. manufactured pharmaceutical company. It developed novel diagnostics and therapeutics, which address unmet medical needs. It used to researches, develops, manufactures and markets ethical pharmaceuticals in five strategic areas such as female healthcare, diagnostic imaging, dermatology, oncology and therapeutics. The company was headquartered in Wayne, NJ | Health Technology |
- Bourse
- Insiders
- Israel Rios
- Expérience